MiR-143/145 deficiency attenuates the progression of atherosclerosis in Ldlr-/- mice

Thrombosis and Haemostasis

Volumn 112, Issue 4, 2014, Pages 796-802

  Sala, Federica ^a   Aranda, Juan F ^b   Rotllan, Noemi ^b   Ramírez, Cristina M ^b   Aryal, Binod ^b   Elia, Leonardo ^c,d   Condorelli, Gianluigi ^c   Catapano, Alberico Luigi ^d   Fernández Hernando, Carlos ^b   Norata, Giuseppe Danilo ^a,e,f  

^a UNIVERSITY OF MILAN   (Italy)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d IRCCS MULTIMEDICA   (Italy)

^e Bassini Hospital   (Italy)

^f QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

ABCA1; Atherosclerosis; MiR 143 145; Smooth muscle cells

Indexed keywords

ABC TRANSPORTER A1; ALPHA ACTIN; BIGLYCAN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MICRORNA 143; MICRORNA 145; TRANSGELIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; 3' UNTRANSLATED REGION; LIPID; LOW DENSITY LIPOPROTEIN; MICRORNA; MIRN143 MICRORNA, MOUSE; MIRN145 MICRORNA, MOUSE;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; DISEASE COURSE; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; LIPID ANALYSIS; LIPID DIET; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; ANIMAL; CAROTID ARTERY; CELL DIFFERENTIATION; CELL MOTION; CHEMISTRY; CYTOLOGY; GENETICS; KNOCKOUT MOUSE; MACROPHAGE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHENOTYPE;

3' UNTRANSLATED REGIONS; ANIMALS; ATHEROSCLEROSIS; BASE SEQUENCE; CAROTID ARTERIES; CELL DIFFERENTIATION; CELL MOVEMENT; DISEASE PROGRESSION; FEMALE; LIPIDS; LIPOPROTEINS, LDL; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; MICRORNAS; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; PHENOTYPE; PLAQUE, ATHEROSCLEROTIC; RECEPTORS, LDL;

EID: 84908519519     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH13-11-0905     Document Type: Article

References (21)

1. Albinsson S, Sessa WC. Can microRNAs control vascular smooth muscle phenotypic modulation and the response to injury? Physiological Genom 2011; 43: 529-533.
2. Albinsson S, Skoura A, Yu J, et al. Smooth muscle miRNAs are critical for postnatal regulation of blood pressure and vascular function. PloS one 2011; 6: e18869.
3. Albinsson S, Suarez Y, Skoura A, et al. MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function. Arterioscl Thromb Vasc Biol 2010; 30: 1118-1126.
4. Norata GD, Sala F, Catapano AL, et al. MicroRNAs and lipoproteins: a connection beyond atherosclerosis? Atherosclerosis 2013; 227: 209-215.
5. Cordes KR, Sheehy NT, White MP, et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009; 460: 705-710.
6. Elia L, Quintavalle M, Zhang J, et al. The knockout of miR-143 and-145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ 2009; 16: 1590-1598.
7. Xin M, Small EM, Sutherland LB, et al. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev 2009; 23: 2166-2178.
8. Boettger T, Beetz N, Kostin S, et al. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J Clin Invest 2009; 119: 2634-2647.
9. Hergenreider E, Heydt S, Treguer K, et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nature Cell Biol 2012; 14: 249-256.
10. Rader DJ, Parmacek MS. Secreted miRNAs suppress atherogenesis. Nature Cell Biol 2012; 14: 233-235.
11. Norata GD, Pinna C, Zappella F, et al. MicroRNA 143-145 deficiency impairs vascular function. Int J Immunopathol Pharmacol 2012; 25: 467-474.
12. Cipollone F, Felicioni L, Sarzani R, et al. A unique microRNA signature associated with plaque instability in humans. Stroke 2011; 42: 2556-2563.
13. Norata GD, Venu VK, Callegari E, et al. Effect of Tie-2 conditional deletion of BDNF on atherosclerosis in the ApoE null mutant mouse. Biochim Biophys Acta 2012; 1822: 927-935.
14. Shimizu-Hirota R, Sasamura H, Kuroda M, et al. Extracellular matrix glycoprotein biglycan enhances vascular smooth muscle cell proliferation and migration. Circulation Res 2004; 94: 1067-1074.
15. Jordan SD, Kruger M, Willmes DM, et al. Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nature Cell Biol 2011; 13: 434-446.
16. Lovren F, Pan Y, Quan A, et al. MicroRNA-145 targeted therapy reduces atherosclerosis. Circulation 2012; 126 (11 Suppl 1): S81-90.
17. Kang MH, Zhang LH, Wijesekara N, et al. Regulation of ABCA1 protein expression and function in hepatic and pancreatic islet cells by miR-145. Arterioscler Thromb Vasc Biol 2013; 33: 2724-2732.
18. Rong JX, Shapiro M, Trogan E, et al. Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading. Proc Natl Acad Sci USA 2003; 100: 13531-13536.
19. Esau C, Kang X, Peralta E, et al. MicroRNA-143 regulates adipocyte differentiation. J Biol Chem 2004; 279: 52361-52365.
20. Norata GD, Tibolla G, Catapano AL. Gene silencing approaches for the management of dyslipidaemia. Trends Pharmacol Sci 2013; 34: 198-205.
21. Norata GD, Ballantyne CM, Catapano AL. New therapeutic principles in dyslipidaemia: focus on LDL and Lp(a) lowering drugs. Eur Heart J 2013; 34: 1783-1789.